 | | Neuroscientist awarded $4.6 million for promising pan-cancer immunotherapy | | | The grant was given to Michael Demetriou, MD, PhD, to accelerate his lab’s groundbreaking work on genetically modified chimeric antigen receptor (CAR) T cells. Read More | | |
 | | Answers for Cancers | | | The UCI Anti-Cancer Challenge supports promising studies, including the Stopgap trial. Read More | | |
|
|